vs
Arcutis Biotherapeutics, Inc.（ARQT）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
Arcutis Biotherapeutics, Inc.的季度营收约是Resolute Holdings Management, Inc.的1.1倍（$129.5M vs $117.7M），Arcutis Biotherapeutics, Inc.净利率更高（13.4% vs -1.5%，领先14.9%）
Arcutis Biotherapeutics是一家临床阶段生物制药企业，专注于开发和商业化免疫介导皮肤病领域的创新处方疗法，产品管线覆盖银屑病、特应性皮炎、斑秃等适应症，主要服务美国市场的患者及医疗服务提供者，填补皮肤科诊疗领域的未满足需求。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
ARQT vs RHLD — 直观对比
营收规模更大
ARQT
是对方的1.1倍
$117.7M
净利率更高
ARQT
高出14.9%
-1.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $129.5M | $117.7M |
| 净利润 | $17.4M | $-1.7M |
| 毛利率 | 91.0% | 55.7% |
| 营业利润率 | 14.2% | 30.2% |
| 净利率 | 13.4% | -1.5% |
| 营收同比 | 81.5% | — |
| 净利润同比 | 261.2% | — |
| 每股收益（稀释后） | $0.14 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARQTRHLD
| Q4 25 | $129.5M | $117.7M | ||
| Q3 25 | $99.2M | $120.9M | ||
| Q2 25 | $81.5M | $119.6M | ||
| Q1 25 | $65.8M | $103.9M | ||
| Q4 24 | $71.4M | — | ||
| Q3 24 | $44.8M | — | ||
| Q2 24 | $30.9M | — | ||
| Q1 24 | $49.6M | — |
净利润ARQTRHLD
| Q4 25 | $17.4M | $-1.7M | ||
| Q3 25 | $7.4M | $-231.0K | ||
| Q2 25 | $-15.9M | $-611.0K | ||
| Q1 25 | $-25.1M | $-3.4M | ||
| Q4 24 | $-10.8M | — | ||
| Q3 24 | $-41.5M | — | ||
| Q2 24 | $-52.3M | — | ||
| Q1 24 | $-35.4M | — |
毛利率ARQTRHLD
| Q4 25 | 91.0% | 55.7% | ||
| Q3 25 | 91.2% | 59.0% | ||
| Q2 25 | 90.8% | 57.5% | ||
| Q1 25 | 86.6% | 52.5% | ||
| Q4 24 | 90.3% | — | ||
| Q3 24 | 87.7% | — | ||
| Q2 24 | 88.8% | — | ||
| Q1 24 | 93.4% | — |
营业利润率ARQTRHLD
| Q4 25 | 14.2% | 30.2% | ||
| Q3 25 | 8.6% | 34.3% | ||
| Q2 25 | -17.9% | 34.0% | ||
| Q1 25 | -37.3% | 24.7% | ||
| Q4 24 | -10.7% | — | ||
| Q3 24 | -87.3% | — | ||
| Q2 24 | -162.3% | — | ||
| Q1 24 | -63.8% | — |
净利率ARQTRHLD
| Q4 25 | 13.4% | -1.5% | ||
| Q3 25 | 7.5% | -0.2% | ||
| Q2 25 | -19.5% | -0.5% | ||
| Q1 25 | -38.1% | -3.2% | ||
| Q4 24 | -15.1% | — | ||
| Q3 24 | -92.8% | — | ||
| Q2 24 | -169.6% | — | ||
| Q1 24 | -71.4% | — |
每股收益（稀释后）ARQTRHLD
| Q4 25 | $0.14 | $-0.20 | ||
| Q3 25 | $0.06 | $-0.03 | ||
| Q2 25 | $-0.13 | $-0.07 | ||
| Q1 25 | $-0.20 | $-0.39 | ||
| Q4 24 | $-0.09 | — | ||
| Q3 24 | $-0.33 | — | ||
| Q2 24 | $-0.42 | — | ||
| Q1 24 | $-0.32 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $42.9M | $205.5M |
| 总债务越低越好 | $109.0M | $169.8M |
| 股东权益账面价值 | $189.5M | $6.5M |
| 总资产 | $433.0M | $333.4M |
| 负债/权益比越低杠杆越低 | 0.58× | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资ARQTRHLD
| Q4 25 | $42.9M | $205.5M | ||
| Q3 25 | $47.1M | $148.0M | ||
| Q2 25 | $72.7M | $99.9M | ||
| Q1 25 | $53.1M | $71.0M | ||
| Q4 24 | $71.3M | — | ||
| Q3 24 | $134.9M | — | ||
| Q2 24 | $84.3M | — | ||
| Q1 24 | $190.1M | — |
总债务ARQTRHLD
| Q4 25 | $109.0M | $169.8M | ||
| Q3 25 | $108.5M | $173.4M | ||
| Q2 25 | $108.0M | $177.1M | ||
| Q1 25 | $107.6M | $180.7M | ||
| Q4 24 | $107.2M | — | ||
| Q3 24 | $204.6M | — | ||
| Q2 24 | $203.8M | — | ||
| Q1 24 | $202.8M | — |
股东权益ARQTRHLD
| Q4 25 | $189.5M | $6.5M | ||
| Q3 25 | $158.1M | $10.8M | ||
| Q2 25 | $139.0M | $9.6M | ||
| Q1 25 | $142.7M | $8.9M | ||
| Q4 24 | $157.5M | — | ||
| Q3 24 | $156.6M | — | ||
| Q2 24 | $186.4M | — | ||
| Q1 24 | $224.9M | — |
总资产ARQTRHLD
| Q4 25 | $433.0M | $333.4M | ||
| Q3 25 | $371.0M | $293.2M | ||
| Q2 25 | $352.4M | $253.3M | ||
| Q1 25 | $344.1M | $214.3M | ||
| Q4 24 | $348.9M | — | ||
| Q3 24 | $437.4M | — | ||
| Q2 24 | $444.8M | — | ||
| Q1 24 | $478.5M | — |
负债/权益比ARQTRHLD
| Q4 25 | 0.58× | 26.03× | ||
| Q3 25 | 0.69× | 16.01× | ||
| Q2 25 | 0.78× | 18.42× | ||
| Q1 25 | 0.75× | 20.38× | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | 1.31× | — | ||
| Q2 24 | 1.09× | — | ||
| Q1 24 | 0.90× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.2M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | — | $189.2M |
| 自由现金流率自由现金流/营收 | — | 160.8% |
| 资本支出强度资本支出/营收 | 0.0% | 5.8% |
| 现金转化率经营现金流/净利润 | 1.51× | — |
| 过去12个月自由现金流最近4个季度 | — | $313.2M |
8季度趋势，按日历期对齐
经营现金流ARQTRHLD
| Q4 25 | $26.2M | $196.1M | ||
| Q3 25 | $-1.8M | $59.6M | ||
| Q2 25 | $324.0K | $48.9M | ||
| Q1 25 | $-30.4M | $18.4M | ||
| Q4 24 | $-748.0K | — | ||
| Q3 24 | $-34.7M | — | ||
| Q2 24 | $-45.1M | — | ||
| Q1 24 | $-31.6M | — |
自由现金流ARQTRHLD
| Q4 25 | — | $189.2M | ||
| Q3 25 | — | $58.6M | ||
| Q2 25 | $246.0K | $47.5M | ||
| Q1 25 | $-31.0M | $17.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-34.8M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率ARQTRHLD
| Q4 25 | — | 160.8% | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | 0.3% | 39.7% | ||
| Q1 25 | -47.1% | 17.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | -77.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ARQTRHLD
| Q4 25 | 0.0% | 5.8% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.1% | 1.2% | ||
| Q1 25 | 0.9% | 0.6% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率ARQTRHLD
| Q4 25 | 1.51× | — | ||
| Q3 25 | -0.24× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
